At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,457 enrolled
Drug / intervention
AMS Penile Prosthesis Devicesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Registry of Outcomes With Penile Prosthesis for Erectile Restoration (PROPPER)
In Brief
An observational study evaluating AMS Penile Prosthesis Devices for Erectile Dysfunction and Impotence. Completed, enrolled 1,457 participants across 11 sites in 2 countries.
Detailed Summary
The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction, Impotence
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJun 2011
Primary CompletionNov 2017
Study CompletionJul 2018
TodayJul 2026
First PostedJun 28, 2011
Enrollment StartJun 13, 2011
Primary CompletionNov 30, 2017
Study CompletionJul 25, 2018
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 15.0 years ago
Interventions
AMS Penile Prosthesis Devicesdevice
Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.